Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • homebuilder_watcher homebuilder_watcher Mar 1, 2007 2:13 PM Flag

    Next week

    IMS data released today confirmed strong January Dacogen sales trend indicted by Oncln 2 weeks ago..sales rose by 25% in January. The absolute number, $9.54 MM translates to a $114 MM run rate. Assuming a modest 50 patient/month growth rate for the rest of the year, 2007 sales could be as high as $120 MM, or 20-30% higher than the guidance of $90-$100 MM give by partner MGI Pharma. We observe that while Dacogen is growing steadily, Vidaza was relatively flat at $11 MM in January.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think its safe to say that dacogen will grow within the year due to little competition. Normally when a new product reaches market more doctors are willing to use it compared to old. However the real issue is supgen next product or the wanabee drug.

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT